COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases.

ABSTRACT:

Background

Mucormycosis, a rare fungal infection, has shown an increase in the number of reported cases during the COVID-19 pandemic.

Objectives

To provide a comprehensive insight into the characteristics of COVID-19-associated mucormycosis, through a systematic review and meta-analysis.

Methods of data synthesis

Demographic information and clinical features were documented for each patient. Logistic regression analysis was used to predict the risk of mortality.

Data sources

PubMed, Scopus, Web of Science, Cochrane, CINAHL, Ovid MEDLINE, and FungiSCOPE.

Study eligibility criteria

Studies reporting individual-level information in patients with adult COVID-19-associated mucormycosis (CAM) between 1 January 2020 and 28 December 2022.

Participants

Adu

SUBMITTER: Ozbek L 

PROVIDER: S-EPMC10008766 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature